Follow us :
日本デスク
Site en français
Conseils en Propriété Industrielle / European Patent and Trademark Attorneys
PARIS
LYON
RENNES
MONTPELLIER
GRENOBLE
TOULOUSE
MUNICH
Client Login
News
Events
In France and abroad
Legal News
Current IP News
Press Room
Press Releases
INFORMATION COVID-19
Expertise
Patents
Life Sciences and Chemistry
IT / Mechanics / Physics
Focus on our EP Practice
Unitary Patent
Trademarks & Designs
Our expertise
Contracts, IP valuation & Data
Drafting of your contracts
IP asset valuation
GDPR compliance
IP Intelligence
Patentability Study
Freedom to operate
Anticipating developments
For the last 80 years, we have been assisting our clients in protecting, developing and defending their innovations and creations.
Training
IP TRAINING
IP Academy
5-day seminar
Publications
Last Published
Current IP News
published by our IP Attorneys
Search for a publication
All our articles organised
by theme, author, IP rights
Focus on
Discover a selection of our publications arranged by topic.
IPON Newsletter
Read our latest newsletter
Team
Partners
Our team
Find your contact among our employees
REGIMBEAU's Network
Our network of International Associates and our involvement in Professional Organisations
日本デスク
Japan Desk
Careers
Join us
Discover our current employment offers and send your application
Contact us
Paris
Lyon
Rennes
Montpellier
Grenoble
Toulouse
Munich
Home
>
Team
>
Our team
>
CV
Our team
Patents - Life Sciences & Chemistry
Frédérique FAIVRE PETIT
Barbara CASADEWALL
Anne BOGARD BOUTARIC
Stéphanie CELAIRE
Emmanuelle LEVY
Armelle LEONARD
Nicolas BOUQUIN
Soizic GUINDEUIL
Cécile PUECH
Margaux BERETTA
Isabelle BOSSER
Lazarina CHOISNEL
Gabrielle FAURE-ANDRE
Raphaëlle GILLET
Marion GIZZI
Sara HAINES
Ludovic LE GUEN
Aurélia VAVASSEUR
Lucile VERNOUX
Patents - IT/Mechanics/Physics
Trademarks & Designs
Contracts, IP Valuation & Data
IP Intelligence
IP Administration
Search by name
Sara HAINES, Ph.D
US Patent Agent
European Patent Attorney
Life Sciences & Chemistry Department
AGENCIES:
LYON
Email: haines@regimbeau.eu
Tel: +33 4 72 83 85 70
Languages:
Qualifications
European Patent Attorney
Education
Bachelor of Science in Microbiology and Chemistry (Oregon State University, USA)
MS in Sciences and Technologies (Université Pierre et Marie Curie, Paris VI)
Ph.D in Microbiology (Université de Lyon)
CEIPI Graduate (Distinction in “Patents”)
Background
After five years research experience in the pharmaceutical industry and an initial experience in an IP Law firm, Sara HAINES joined REGIMBEAU in 2016.
Technical and scientific fields
Agronomy, Molecular and cellular biology, Biochemistry, Medical devices, Genetic engineering, Immunology, Microbiology, Vaccinations
Recent contributions and participations
Online
Antibody Industrial Symposium 2020
Contribution on the Challenges & Perspectives of Intellectual Property in Immunotherapy by
Raphaëlle GILLET
, French and European Patent Attorney and
Sara HAINES
, US Patent Agent to AIS congress 2020.
23th Nov 2020
Lyon
CLARA Forum
Participation of
Lucile VERNOUX
and
Sara HAINES
at CLARA Cancer Research Forum.
4th April 2019
Recent Publications
BIG BANG - Transition date for new sequence listing standard
By
Raphaëlle GILLET
and
Sara HAINES
, European Patent Attorneys
The new ST.26 standard has been established by the World Intellectual Property Organization (WIPO) for sequence listings. It has the advantage of providing a single format that is acceptable for all international and national procedures.
Published on: 20th Oct 2021
Patent
35 USC § 101: Further clarification of patent subject-matter eligibility.
By
Sara HAINES
, US Patent Agent.
Two recently issued USPTO memorandums further clarify aspects of patent subject-matter eligibility under 35 USC § 101. The Vanda memo1 specifies methods of treatment that should be considered to be patent eligible under step 2A of the Alice/Mayo test2 thereby avoiding any further analysis under step 2B, while the Berkheimer memo3 states that examiners must provide substantiated evidence when additional claim elements are considered to represent well-understood, routine, conventional activity in support of 35 USC § 101 rejections under step 2B.
Published on: 30th Oct 2018
Patent
Patentability of Biological Material
Biomarkers
Fields
Patent
Know-how
IP Prosecution
Portfolio management
Last published
BIG BANG - Transition date for new sequence listing standard
By
Raphaëlle GILLET
and
Sara HAINES
, European Patent Attorneys
The new ST.26 standard has been established by the World Intellectual Property Organization (WIPO) for sequence listings. It has the advantage of providing a single format that is acceptable for all international and national procedures.
Published on: 20th Oct 2021
Patent
All publications
Discover the
Life Sciences and Chemistry